Announced Fri, 17 Apr · 18:55 IST
Johnson Pharmacare appoints father-son duo as Additional Directors
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹0.62
prior close
₹0.66
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.5-3.0-3.0-3.0-3.2-1.6-4.8-4.8+0.0-4.8-11.3-12.9-19.4-22.6
Up moveDown movePending
AI summary
On April 17, 2026, Johnson Pharmacare's Board approved the appointment of Mr. Nand Kishore Ray (DIN: 11626638) as Additional Non-Executive & Non-Independent Director and his son Mr. Dheeraj Kumar (DIN: 11666616, DOB 01/01/2005) as Additional Executive Director. Both are from Muzaffarpur, Bihar, and submitted non-debarment declarations.
Likely market impact
Family-based board expansion with a very young (21) executive director; investors may monitor for governance and succession implications.